Texas A&M Oral Pathology Services

CLIA Laboratory Citation Details

2
Total Citations
5
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 45D0659611
Address 3302 Gaston Ave, Dallas, TX, 75246
City Dallas
State TX
Zip Code75246
Phone(214) 828-8100

Citation History (2 surveys)

Survey - March 24, 2025

Survey Type: Standard

Survey Event ID: CRML11

Deficiency Tags: D5417 D5417 D0000

Summary:

Summary Statement of Deficiencies D0000 The laboratory was found to be in substantial compliance with CLIA regulations 42 CFR Part 493. Standard level deficiency was cited. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) (d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on surveyor observation, review of patient annual volumes, and confirmed in interview, the laboratory failed to ensure expired reagents were not available for use prior to patient testing for five of five tissue marking reagents observed in March 2025. Findings included: 1. During a tour of the laboratory at 11:23 AM, the surveyor observed five tissue marking reagents on the laboratory counter available for use. The surveyor observed the following printed on the inking reagents: a. Lot Number: 111147 Color: Green Expiration: 11/30/2022 b. Lot Number: 109671 Color: yellow Expiration: 11/30/2022 c. Lot Number: 109668 Color: Red Expiration: 11/30/2022 d. Lot Number: 108664 Color: Orange Expiration: 11/30/2022 e. Lot Number: 112652 Color: Black Expiration: 11/30/2022 The surveyor inquired if the expired reagent were currently being used to test patient samples. The laboratory director confirmed the expired reagents were currently in use for patient testing. 2. Review of patient annual volumes from March 2024-March 2025, revealed the laboratory performed 71 patient tests using the expired tissue marking reagent. 3. In an interview on 03/24 /2025 at 11:35 AM in the facility conference room, the laboratory director confirmed the above findings. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 16, 2019

Survey Type: Standard

Survey Event ID: NYMY11

Deficiency Tags: D5203 D5203

Summary:

Summary Statement of Deficiencies D5203 SPECIMEN IDENTIFICATION AND INTEGRITY CFR(s): 493.1232 The laboratory must establish and follow written policies and procedures that ensure positive identification and optimum integrity of a patient's specimen from the time of collection or receipt of the specimen through completion of testing and reporting of results. This STANDARD is not met as evidenced by: . Based on surveyor observation, confirmed by staff interview, the laboratory failed to employ procedures to ensure positive identification of patient histopathology testing. Findings: a. During the survey on 07/16-2019, the surveyor observed a patient specimen bottle and Slide in the laboratory with out two unique identifier The specimens were with the patients' first and last names only. b. In an interview with the laboratory Director at the site on 07/16/-2019, testing stated that the specimens are only labeled with the name only and failed be labeled with two unique identifiers confirmed 07/16/2019 at 14:30 hrs . Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access